Syndax Pharmaceuticals, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on November 2, 2026, disclosing the retirement of Chief Financial Officer Keith A. Goldan and the appointment of Aaron A. Ondrey as his successor, both effective November 9, 2026, alongside the …
Morgan Stanley Finance LLC filed a Free Writing Prospectus on November 2, 2026, summarizing terms for Worst-of SLV, NDXT, and RTY Contingent Income Memory Auto-Callable Securities due December 5, 2029, under Registration Statement Nos. 333-293641 and 333-293641-01.
Morgan Stanley Finance LLC filed a free writing prospectus on November 2, 2026, disclosing preliminary terms for its SPUMP40 Contingent Income Memory Buffered Auto-Callable Securities due November 28, 2031, under Registration Statement Nos. 333-293641 and 333-293641-01.
Morgan Stanley Finance LLC filed a Free Writing Prospectus on November 2, 2026, disclosing preliminary terms for Contingent Income Memory Buffered Auto-Callable Securities linked to the S&P U.S. Equity Momentum 40% VT 4% Decrement Index, due November 28, 2031.
Director Kathleen Louise Kiernan filed a statement of changes in beneficial ownership with the SEC on November 2, 2026, disclosing the acquisition of 2,510 shares of common stock in Rank One Computing Corp (NASDAQ:ROC) on September 1, 2026.
Director Steven Mark Martinez filed a statement of changes in beneficial ownership with the SEC on November 2, 2026, reporting the acquisition of 7,294 shares of Rank One Computing Corp common stock on September 1, 2026.
Morgan Stanley Finance LLC filed Free Writing Prospectus No. 19,706 on November 2, 2026, summarizing the preliminary terms of Worst-of INDU, SX5E and RTY Contingent Income Auto-Callable Securities due November 29, 2029.
Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 19,712 on November 2, 2026, relating to Worst-of NDXT, RTY and SPX Contingent Income Auto-Callable Securities due May 30, 2028.
Daily Journal Corporation filed an 8-K on November 2, 2026, disclosing a new CEO Compensation Agreement with Steven Myhill-Jones and a CFO Letter Agreement with Erik Nakamura, both effective during the company's 2026 and 2027 fiscal years, respectively.
Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 19,788 on November 2, 2026, outlining terms for Fixed Income Buffered Auto-Callable Securities linked to the S&P U.S. Equity Momentum 40% VT 4% Decrement Index, with a stated maturity date …